CT
GILD icon

Caldwell Trust’s Gilead Sciences GILD Stock Holding History

Caldwell Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155K Buy
1,224
+131
+12% +$17.3K 0.01% 357
2026
Q1 		$152K Hold
1,093
– – 0.01% 361
2025
Q4 		$134K Hold
1,093
– – 0.01% 369
2025
Q3 		$121K Hold
1,093
– – 0.01% 367
2025
Q2 		$121K Sell
1,093
-51
-4% -$5.43K 0.01% 362
2025
Q1 		$128K Buy
1,144
+246
+27% +$25.4K 0.01% 356
2024
Q4 		$82.9K Sell
898
-221
-20% -$19.9K 0.01% 400
2024
Q3 		$93.8K Buy
1,119
+151
+16% +$11.5K 0.01% 384
2024
Q2 		$66.4K Sell
968
-125
-11% -$8.34K 0.01% 419
2024
Q1 		$80.1K Hold
1,093
– – 0.01% 404
2023
Q4 		$88.5K Sell
1,093
-186
-15% -$14.5K 0.01% 381
2023
Q3 		$95.8K Sell
1,279
-100
-7% -$7.69K 0.01% 361
2023
Q2 		$106K Buy
1,379
+38
+3% +$3.03K 0.01% 356
2023
Q1 		$111K Buy
1,341
+233
+21% +$19.3K 0.02% 339
2022
Q4 		$95.1K Sell
1,108
-2
-0.2% -$158 0.01% 347
2022
Q3 		$68.5K Sell
1,110
-3
-0.3% -$189 0.01% 380
2022
Q2 		$68.8K Buy
1,113
+45
+4% +$2.79K 0.01% 401
2022
Q1 		$63.5K Sell
1,068
-50
-4% -$3.2K 0.01% 432
2021
Q4 		$81.2K Hold
1,118
– – 0.01% 396
2021
Q3 		$78.1K Sell
1,118
-340
-23% -$23.9K 0.01% 389
2021
Q2 		$100K Hold
1,458
– – 0.01% 363
2021
Q1 		$94.2K Sell
1,458
-125
-8% -$8.06K 0.01% 356
2020
Q4 		$92.2K Hold
1,583
– – 0.01% 347
2020
Q3 		$100K Hold
1,583
– – 0.02% 321
2020
Q2 		$122K Buy
1,583
+200
+14% +$15.3K 0.02% 301
2020
Q1 		$103K Sell
1,383
-79
-5% -$5.46K 0.02% 318
2019
Q4 		$95K Buy
+1,462
New +$95.2K 0.01% 370

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Caldwell Trust's GILD Position: Q2 2026 in Review

Caldwell Trust increased its Gilead Sciences (GILD) stake by 12% in Q2 2026, buying an estimated $17.3K and bringing the position to 1,224 shares worth $155K. The position accounts for 0.01% of the portfolio, ranked #357.

Caldwell Trust first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Caldwell Trust held 1,224 shares of Gilead Sciences worth $155K as of Q2 2026.
  • Caldwell Trust bought 131 Gilead Sciences shares in Q2 2026, an estimated $17.3K.
  • Gilead Sciences made up 0.01% of Caldwell Trust's portfolio in Q2 2026, its #357 holding.
  • Caldwell Trust first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Caldwell Trust's 13F filing for Q2 2026, filed 3 Aug 2026.